Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 23;16(11):1578.
doi: 10.3390/nu16111578.

Feasibility and Safety of the Early Introduction of Allergenic Foods in Asian Infants with Eczema

Affiliations

Feasibility and Safety of the Early Introduction of Allergenic Foods in Asian Infants with Eczema

Daisuke Harama et al. Nutrients. .

Abstract

Background: There is a lack of data regarding the early introduction of the consumption of allergenic food among Asian infants.

Methods: We examined infants who had early-onset eczema before 6 months of age and received instructions from certified allergists for the early introduction of hen's eggs, milk, wheat, peanuts, and tree nuts.

Results: The consumption rates of hen's eggs were 100% at 24 months. For peanuts and walnuts, the consumption rate was moderate at 12 months (48.5% and 30.3%, respectively), but by 24 months, it had progressed to 78.8% and 81.3%, respectively. In contrast, cashews remained at lower levels than other allergens at 20.7% at 12 months and 41.4% at 24 months. No adverse events related to early introductions occurred.

Conclusions: In infants with eczema, allergenic foods could be introduced early and well tolerated in Asian infants. However, having eczema may indicate a predisposition to food allergies, so caution is necessary when introducing allergenic foods. The early introduction of peanuts and tree nuts was still more challenging in real-world practice in Asia as well as in Western countries.

Keywords: early introduction; eczema; food allergy; infant.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Flow chart of the study.
Figure 2
Figure 2
Trend in specific IgE levels and TARC with age by month. Allergen-specific IgE, total IgE, and TARC at 6, 12, and 24 months were investigated for participants whose allergists considered it necessary. Median (IQR) values at 6, 12, and 24 months, respectively, were as follows: total IgE 17.8 (6.98–40.0) IU/mL, 48.9 (31.0–111.0) IU/mL, and 87.2 (59.1–149.0) IU/mL; TARC 1520.5 (964.8–2048) pg/mL, 876.0 (721.0–1287) pg/mL, and 908.5 (706.0–1135) pg/mL; Egg 4.70 (1.40–48.0) UA/mL, 9.41 (3.02–37.9) UA/mL, and 4.89 (2.06–51.9) UA/mL; OVM 0 (0–2.70) UA/mL, 1.37 (0.3–4.41) UA/mL, and 0.5 (0.26–2.50) UA/mL. * indicates statistical significance, p < 0.01. NT: not tested, OVM: ovomucoid.
Figure 3
Figure 3
The consumption rate of hen’s egg, peanuts, walnuts, and cashew nuts.
Figure 4
Figure 4
The consumption rate of hen’s egg, peanuts, walnuts, and cashew nuts between sensitized and non-sensitized infants. The white bar shows infants without sanitization, and the black bar shows infants with sensitization.

Similar articles

References

    1. Loh W., Tang M.L.K. The Epidemiology of Food Allergy in the Global Context. Int. J. Environ. Res. Public Health. 2018;15:2043. doi: 10.3390/ijerph15092043. - DOI - PMC - PubMed
    1. Jones S.M., Kim E.H., Nadeau K.C., Nowak-Wegrzyn A., Wood R.A., Sampson H.A., Scurlock A.M., Chinthrajah S., Wang J., Pesek R.D., et al. Efficacy and Safety of Oral Immunotherapy in Children Aged 1–3 Years with Peanut Allergy (the Immune Tolerance Network IMPACT Trial): A Randomised Placebo-Controlled Study. Lancet. 2022;399:359–371. doi: 10.1016/S0140-6736(21)02390-4. - DOI - PMC - PubMed
    1. Natsume O., Kabashima S., Nakazato J., Yamamoto-Hanada K., Narita M., Kondo M., Saito M., Kishino A., Takimoto T., Inoue E., et al. Two-Step Egg Introduction for Prevention of Egg Allergy in High-Risk Infants with Eczema (PETIT): A Randomised, Double-Blind, Placebo-Controlled Trial. Lancet. 2017;389:276–286. doi: 10.1016/S0140-6736(16)31418-0. - DOI - PubMed
    1. Du Toit G., Roberts G., Sayre P.H., Bahnson H.T., Radulovic S., Santos A.F., Brough H.A., Phippard D., Basting M., Feeney M., et al. Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy. N. Engl. J. Med. 2015;372:803–813. doi: 10.1056/NEJMoa1414850. - DOI - PMC - PubMed
    1. Sakihara T., Otsuji K., Arakaki Y., Hamada K., Sugiura S., Ito K. Randomized Trial of Early Infant Formula Introduction to Prevent Cow’s Milk Allergy. J. Allergy Clin. Immunol. 2021;147:224–232.e8. doi: 10.1016/j.jaci.2020.08.021. - DOI - PubMed